Fennec Pharmaceuticals Inc. balance sheet

At the end of fiscal 2025, Fennec Pharmaceuticals Inc. had total assets of $70.6m, total liabilities of $35.1m and shareholders' equity of $35.5m. It held $36.8m in cash against $19.4m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fennec Pharmaceuticals Inc.: balance sheet, annual
Fiscal year	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	5	2	2	2	1	4	28	23	14	30	24	13	27	37	41
Receivables	—	—	—	—	—	—	—	—	—	—	2	9	13	23	23
Total current assets	—	—	—	—	—	—	28	23	14	31	27	27	44	67	73
Total assets	5	2	2	2	1	4	28	23	14	31	27	27	45	71	76
Accounts payable	0	0	0	0	0	0	1	1	2	2	2	4	3	5	6
Deferred revenue (current)	—	—	—	—	—	—	—	—	—	—	—	—	0	0	3
Total current liabilities	5	7	3	2	0	0	2	2	2	2	5	8	7	11	12
Long-term debt	—	—	—	—	—	—	—	—	—	—	25	31	19	—	—
Total debt	0	0	0	0	0	0	0	0	0	0	25	31	19	19	—
Total liabilities	5	7	3	2	0	0	2	2	2	2	30	38	51	35	33
Shareholders' equity	−0	−5	−1	1	1	4	27	21	12	29	−3	−12	−6	35	42
Shares outstanding	25m	25m	10m	11m	11m	14m	18m	20m	20m	26m	26m	27m	28m	34m	35m

US$ millions unless shown otherwise. Fiscal quarters.

Fennec Pharmaceuticals Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	13	13	15	18	19	23	19	23
Total current assets	58	44	43	41	46	67	67	73
Total assets	59	45	46	45	49	71	72	76
Accounts payable	4	3	5	6	6	5	6	6
Deferred revenue (current)	0	0	0	0	0	0	0	3
Total current liabilities	7	7	8	8	10	11	10	12
Long-term debt	32	19	19	19	19	—	—	—
Total debt	32	19	19	19	19	—	—	—
Total liabilities	64	51	52	52	54	35	34	33
Shareholders' equity	−5	−6	−6	−7	−4	35	38	42
Shares outstanding	27m	28m	28m	28m	28m	34m	35m	35m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: FENC vs NTLA FENC vs IVVD FENC vs NKTR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Fennec Pharmaceuticals Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Fennec Pharmaceuticals Inc.